INDIANA HEMOPHILIA & THROMBOSIS CENTER

Serial Number 98450963
Registration 7719269
700

Registration Progress

Application Filed
Mar 15, 2024
Under Examination
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered
Mar 11, 2025

Trademark Image

INDIANA HEMOPHILIA & THROMBOSIS CENTER

Basic Information

Serial Number
98450963
Registration Number
7719269
Filing Date
March 15, 2024
Registration Date
March 11, 2025
Published for Opposition
January 21, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 11, 2025
Registration
Registered
Classes
042 044

Rights Holder

Indiana Hemophilia & Thrombosis Center, Inc.

03
Address
8326 Naab Road
Indianapolis, IN 46260

Ownership History

Indiana Hemophilia & Thrombosis Center, Inc.

Original Applicant
03
Indianapolis, IN

Indiana Hemophilia & Thrombosis Center, Inc.

Owner at Publication
03
Indianapolis, IN

Indiana Hemophilia & Thrombosis Center, Inc.

Original Registrant
03
Indianapolis, IN

Legal Representation

Attorney
Thomas A. Walsh

USPTO Deadlines

Next Deadline
2050 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-11)
Due Date
March 11, 2031
Grace Period Ends
September 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Mar 11, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 11, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 19, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 19, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 19, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 19, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 21, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 21, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 21, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 21, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 16, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 15, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 15, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 15, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 25, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 21, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
medical research services; biomedical research services; medical research services in the field of diseases related to blood; medical research services in the field of blood disorders; pharmaceutical research services
First Use Anywhere: Jan 5, 2024
First Use in Commerce: Jan 5, 2024
Class 044
medical services; medical services in the field of diseases related to blood; medical services in the field of blood disorders; pharmaceutical compounding services; preparation of prescriptions in pharmacies
First Use Anywhere: Jan 5, 2024
First Use in Commerce: Jan 5, 2024

Additional Information

Design Mark
The mark consists of the words Indiana Hemophilia & Thrombosis Center and a droplet design.
Color Claim
Color is not claimed as a feature of the mark.
Other
As to "INDIANA HEMOPHILIA & THROMBOSIS CENTER"

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEMOPHILIA & THROMBOSIS CENTER"